PARKINSON’S DISEASE
An estimated seven to ten million people worldwide are living with Parkinson’s disease (PD), which is an incurable and progressive disease of the nervous system affecting movement and cognitive function. More than half of PD patients develop progressive disease showing signs of dementia similar to Alzheimer’s disease. A research team at University of Copenhagen, Denmark, has discovered that non-inheritable PD may be caused by functional changes in the immune regulating gene Interferon-beta (IFN?). Treatment with IFN?-gene therapy successfully prevented neuronal death and disease effects in an experimental model of PD. The results have just been published in prestigious scientific journal Cell.
Protein regulates waste management in nerve cells
The human brain consists of approximately 100 billion neurons, which coordinate activities in all parts of the body. At Biotech Research and Innovation Centre (BRIC), University of Copenhagen, the group of Professor Shohreh Issazadeh-Navikas has discovered that the immune gene IFN? plays a vital role in keeping neurons healthy.
-We found that IFN? is essential for neurons ability to recycle waste proteins. Without this, the waste proteins accumulate in disease-associated structures called Lewy bodies and with time the neurons die, explains assistant professor Patrick Ejlerskov, the first author of this report.
The research team found that mice missing IFN? developed Lewy bodies in parts of the brain, which control body movement and restoration of memory, and as a result they developed disease and clinical signs similar to patients with PD and dementia with Lewy bodies (DLB).
New understanding of non-familial Parkinson’s disease
While hereditary gene mutations have long been known to play a role in familial PD, the study from BRIC offers one of the first models for so-called non-familial PD, which comprises the majority (90-95%) of patients suffering from PD. According to professor Shohreh Issazadeh-Navikas the new knowledge opens new therapeutic possibilities:
–This is one of the first genes found to cause pathology and clinical features of non-familial PD and DLB, through accumulation of disease-causing proteins. It is independent of gene mutations known from familial PD and when we introduced IFN?-gene therapy, we could prevent neuronal death and disease development. Our hope is that this knowledge will enable development of more effective treatment of PD, says professor Shohreh Issazadeh-Navikas.
Read more: Immune gene prevents Parkinson’s disease and dementia
The Latest on: Parkinson’s
[google_news title=”” keyword=”Parkinson’s ” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Parkinson’s
- Podcast: Pesticides, Parkinson's And The Messy Influence Of Geneticson May 13, 2024 at 10:54 am
Tort lawyers regularly bring litigation against pesticide companies alleging that their products cause devastating diseases. Of course, our genetic makeup profoundly influences our risk for certain ...
- PhotoPharmics Enrolls First 25 Patients in Pivotal Parkinson’s Disease Study to Improve Symptoms Beyond the Current Standard of Careon May 13, 2024 at 7:02 am
PhotoPharmics, the leader in specialized phototherapy for neurodegenerative diseases, today announced the successful enrollment of its first 25 patients into the Celeste Light for PD Trial. This ...
- Cannabis compound’s neuroprotective properties revealed — could be key to treating Alzheimer’s and Parkinson’son May 13, 2024 at 7:01 am
Researchers at the Salk Institute found that cannabinol (CBN) and its derivatives could protect brain cells from aging and damage, showing potential for treating neurological disorders like ...
- Little-known signs of Parkinson's disease that are vital to spot early, according to experton May 13, 2024 at 6:34 am
While motor symptoms such as tremors, stiffness, and slowed movements are often the hallmark of Parkinson's, there are subtler indicators that are equally important to be aware of ...
- Buy Rating Reaffirmed for Annovis Bio Amid Positive Prospects for Parkinson’s Treatmenton May 13, 2024 at 3:18 am
Annovis Bio (ANVS – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Ram Selvaraju ...
- Parkinson’s patients with different symptoms take part in new exercise classon May 12, 2024 at 9:46 pm
The long drive from Butler to Allison Park in Allegheny County for exercise workshops was made all the worse for Joann Dellen, who was going to those classes for help with her Parkinson’s disease.
- Parkinson's Newson May 11, 2024 at 5:00 pm
Apr. 30, 2024 — Researchers have found a way to better control the preclinical generation of key neurons depleted in Parkinson's disease, pointing toward a new approach for a disease with no ...
- PHOTOS: Hartford Healthcare hosts 5th Annual Dancing for Parkinson’s eventon May 11, 2024 at 9:08 am
Hartford Healthcare hosted their 5th Annual Starts Dancing for Parkinson’s event Friday, May 10, according to a release.
- Parkinson's Research Newson May 10, 2024 at 5:00 pm
Apr. 30, 2024 — Researchers have found a way to better control the preclinical generation of key neurons depleted in Parkinson's disease, pointing toward a new approach for a disease with no ...
- Researchers' Sexual Misconduct; 'Parkinson's on Steroids'; Need Surgery? Pay Upfronton May 9, 2024 at 9:00 pm
House Republicans are asking HHS Secretary Xavier Becerra to provide the legal basis that requires the agency to hide the names of researchers who have committed sexual misconduct.
via Bing News